• Exchange: New York
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

NVS:US

89.8978 USD 0.1878 0.21%

As of 14:45:42 ET on 08/27/2014.

Snapshot for Novartis AG (NVS)

Open: 90.2500 Day's Range: 89.8200 - 90.2800 Volume: 742,825
Previous Close: 89.7100 52wk Range: 72.2400 - 91.6590 1-Yr Rtn: +25.18%

Stock Chart for NVS

No chart data available.
  • NVS:US 89.8900
  • 1D
  • 1M
  • 1Y
89.7100
Interactive NVS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NVS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 17.3798
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 5.1790
Est. PEG Ratio 2.7101
Market Cap (M USD) 243,584.44
Shares Outstanding (M) 2,706.19
30 Day Average Volume 1,018,072
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 3.07%
Cash Dividend (USD) 2.3383
Dividend Ex-Date 02/27/2014
5 Year Dividend Growth 9.97%
Next Earnings Announcement 10/28/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NVS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NVS

Novartis AG manufactures pharmaceutical and consumer healthcare products. The Company produces pharmaceuticals for cardiovascular, respiratory and infectious diseases, oncology, neuroscience, transplantation, dermatology, gastrointestinal and urinary conditions, and arthritis, vaccines and diagnostics, vision, and animal health products.

Joseph Jimenez Jr "Joe"Chief Executive OfficerHarry KirschChief Financial Officer
Mark C FishmanPresident:NibrCharlotte Pamer-WieserSecretary
More Company Profile & Key Executives for NVS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil